Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cygnus Inc. (NasdaqNM:CYGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
400 Penobscot Drive
Redwood City, CA 94063
Phone: (650) 369-4300
Fax: (650) 599-2503
Employees (last reported count): 112
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 23%
·Over the last 6 months:
 · 16 insider sells; 170.0K shares
  (2.3% of insider shares)
·Institutional: 40% (52% of float)
(151 institutions)
·Net Inst. Selling: 214.0K shares (+1.77%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cygnus Inc. develops and manufactures diagnostic medical devices, utilizing proprietary technologies to satisfy unmet medical needs cost-effectively. The first such device is a frequent, automatic and non-invasive glucose monitoring device, the GlucoWatch biographer, and enhancements thereto. The Company believes that there is an unmet need for automatic, frequent and non-invasive glucose monitoring. In an effort to address this unmet need, the Company has developed the GlucoWatch biographer. The system is comprised of two components: a durable component known as the biographer, and a consumable component known as the AutoSensor. The durable GlucoWatch biographer is worn like a wristwatch and displays and stores current and past glucose levels and trend data. The AutoSensor, after calibration with a standard blood glucose monitor, is attached to the back of the biographer and automatically extracts and measures glucose levels through intact skin every 20 minutes.
More from Market Guide: Expanded Business Description

Financial Summary
Cygnus Inc. develops and manufactures diagnostic medical services, utilizing proprietary technologies. Cygnus currently focuses on glucose monitoring devices. For the six months ended 6/01, revenues totalled $5.1 million, up from $1 million. Net loss increased 45% to $18 million. Results reflect the inclusion of a milestone payment for the Company's GlucoWatch Biographer, offset by expenses to test and develop high-capacity manufacturing processes.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

John Hodgman, 46
Chairman, Pres and CEO
$300K--  
Andre Marion, 65
Vice Chairman
--  --  
Craig Carlson, 53
CFO, Chief Operating Officer, Sr. VP-Fin.
202K$68K
Neil Ackerman, Ph.D., 57
Sr. VP, R&D and Scientific Affiars; CTO
235K227K
Barbara McClung, 46
Sr. VP, Gen. Counsel, Sec.
186K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CYGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$3.188
Recent Price$8.50 
52-Week High
on 8-Sep-2000
$13.313
Beta1.89 
Daily Volume (3-month avg)275.3K
Daily Volume (10-day avg)132.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-30.6%
52-Week Change
relative to S&P500
-6.9%
Share-Related Items
Market Capitalization$261.0M
Shares Outstanding30.7M
Float23.6M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.38 
Earnings (ttm)-$1.37 
Earnings (mrq)-$0.46 
Sales (ttm)$0.19 
Cash (mrq)$0.91 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)45.67 
Income Statements
Sales (ttm)$5.12M
EBITDA (ttm)-$33.2M
Income available to common (ttm)-$37.6M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-106.70%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)1.78 
Debt/EquityN/A 
Total Cash (mrq)$27.8M
Short Interest
As of 8-Aug-2001
Shares Short4.24M
Percent of Float18.0%
Shares Short
(Prior Month)
3.83M
Short Ratio15.52 
Daily Volume273.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.